|
Esketamine Clinical Trials
12 actively recruiting trials across 3 locations
Also known as: (S)-Ketamine, E, Group of patients undergoing gastroenteroscopies with esketamine, JNJ-54135419
Pipeline
Early 1: 1Phase 1: 1Phase 3: 1Phase 4: 4
Top Sponsors
- Women's Hospital School Of Medicine Zhejiang University1
- University of Zagreb1
- Tianjin Medical University General Hospital1
- Second Affiliated Hospital, School of Medicine, Zhejiang University1
- Second Affiliated Hospital of Wenzhou Medical University1
Indications
- Depression8
- Major Depressive Disorder4
- Esketamine3
- Anxiety3
- Preoperative Sedation of Children1
Other9 trials
Atlanta, Georgia1 trial
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Peachford Hospital-Atlanta Behavioral Research
Phase 3
Iowa City, Iowa1 trial
University of Iowa Interventional Psychiatry Service Patient Registry
University of Iowa Health Care
Boston, Massachusetts1 trial
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
Massachusetts General Hospital
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.